These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1491124)

  • 21. Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dose-dependent inhibition of fasting growth hormone secretion.
    Bray MJ; Vick TM; Shah N; Anderson SM; Rice LW; Iranmanesh A; Evans WS; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3143-9. PubMed ID: 11443179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decrease in gonadotropin-releasing hormone (GnRH) pulse frequency with aging in postmenopausal women.
    Hall JE; Lavoie HB; Marsh EE; Martin KA
    J Clin Endocrinol Metab; 2000 May; 85(5):1794-800. PubMed ID: 10843154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165].
    Atkinson C; Warren RM; Sala E; Dowsett M; Dunning AM; Healey CS; Runswick S; Day NE; Bingham SA
    Breast Cancer Res; 2004; 6(3):R170-9. PubMed ID: 15084240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion.
    Baranowska B; Rozbicka G; Jeske W; Abdel-Fattah MH
    J Clin Endocrinol Metab; 1984 Sep; 59(3):412-6. PubMed ID: 6086696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of bone loss in oophorectomized women with a combination of ipriflavone and conjugated equine estrogen.
    Nozaki M; Hashimoto K; Inoue Y; Ogata R; Okuma A; Nakano H
    Int J Gynaecol Obstet; 1998 Jul; 62(1):69-75. PubMed ID: 9722129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of ipriflavone--a synthetic derivative of natural isoflavones--on bone mass loss in the early years after menopause.
    Gennari C; Agnusdei D; Crepaldi G; Isaia G; Mazzuoli G; Ortolani S; Bufalino L; Passeri M
    Menopause; 1998; 5(1):9-15. PubMed ID: 9689189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of conjugated oestrogens on circulating oestradiol, oestrone, LH, FSH and prolactin levels in postmenopausal women.
    Luisi M; Franchi F; Argenio GF; Barletta D; Romano MR; Bernini GP; Gasperi M; Sgrilli R
    Int J Tissue React; 1981 Jun; 3(2):77-81. PubMed ID: 6799393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of urinary and plasma follicle-stimulating hormone by exogenous estrogens in prepubertal and pubertal children.
    Kelch RP; Kaplan SL; Ghumbach MM
    J Clin Invest; 1973 May; 52(5):1122-8. PubMed ID: 4700487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
    Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
    J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of different doses of naloxone on serum levels of prolactin and gonadotropins in young male volunteers.
    Knuth UA; Nieschlag E
    J Endocrinol Invest; 1985 Feb; 8(1):55-7. PubMed ID: 3921597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen replacement therapy in postmenopausal women: a study of the efficacy of estriol and changes in plasma gonadotropin levels.
    Ushiroyama T; Sakai M; Higashiyama T; Ikeda A; Ueki M
    Gynecol Endocrinol; 2001 Feb; 15(1):74-80. PubMed ID: 11293929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adequate reduction degree of pituitary gonadotropin levels in the clinical management of short-term hormone replacement therapy of women with menopausal symptoms.
    Ushiroyama T; Sakuma K; Ikeda A; Ueki M
    J Med; 2004; 35(1-6):281-94. PubMed ID: 18084886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women.
    Baird DD; Umbach DM; Lansdell L; Hughes CL; Setchell KD; Weinberg CR; Haney AF; Wilcox AJ; Mclachlan JA
    J Clin Endocrinol Metab; 1995 May; 80(5):1685-90. PubMed ID: 7745019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration.
    De Lignieres B; Basdevant A; Thomas G; Thalabard JC; Mercier-Bodard C; Conard J; Guyene TT; Mairon N; Corvol P; Guy-Grand B
    J Clin Endocrinol Metab; 1986 Mar; 62(3):536-41. PubMed ID: 3080464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefits of soy germ isoflavones in postmenopausal women with contraindication for conventional hormone replacement therapy.
    Petri Nahas E; Nahás Neto J; De Luca L; Traiman P; Pontes A; Dalben I
    Maturitas; 2004 Aug; 48(4):372-80. PubMed ID: 15283929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women.
    Melis GB; Gambacciani M; Cagnacci A; Paoletti AM; Mais V; Fioretti P
    Obstet Gynecol; 1988 Nov; 72(5):688-92. PubMed ID: 3140150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogenic effects of toremifene and tamoxifen in postmenopausal breast cancer patients.
    Ellmén J; Hakulinen P; Partanen A; Hayes DF
    Breast Cancer Res Treat; 2003 Nov; 82(2):103-11. PubMed ID: 14692654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum estradiol, progesterone, testosterone, FSH and LH levels in postmenopausal women with Alzheimer's dementia.
    Tsolaki M; Grammaticos P; Karanasou C; Balaris V; Kapoukranidou D; Kalpidis I; Petsanis K; Dedousi E
    Hell J Nucl Med; 2005; 8(1):39-42. PubMed ID: 15886752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback.
    Rochira V; Zirilli L; Genazzani AD; Balestrieri A; Aranda C; Fabre B; Antunez P; Diazzi C; Carani C; Maffei L
    Eur J Endocrinol; 2006 Oct; 155(4):513-22. PubMed ID: 16990650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.